Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. Federal Trade Commission
Biotech
AbbVie CEO Gonzalez brushes off FTC concerns for Cerevel buy
AbbVie’s $8.7 billion Cerevel buy will fill in gaps in the pharma’s pipeline with new areas to explore in neuroscience, but will regulators play ball?
Annalee Armstrong
Dec 7, 2023 11:26am
CooperSurgical calls off $875M Cook Medical deal amid FTC probe
Aug 3, 2023 10:57am
Boston Scientific nixes $230M M.I.Tech acquisition
May 25, 2023 12:59pm
Illumina sets deadline for proxy fight over board seats
Apr 21, 2023 10:35am
FTC reverses course, orders Illumina to unravel Grail deal
Apr 3, 2023 12:02pm
Medtronic makes FTC-mandated sale to close Intersect ENT buy
May 13, 2022 11:41am
